Basal-like breast cancer, often referred to as TNBC due to its lack of ER, PR, and HER2 expression, is the most common subtype amongst patients with breast cancer gene 1 (BRCA1) mutations (early-onset) and African American women [21]. This evidence concerns the gene ERBB2 and breast cancer.